Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

SelSym Biotech Inc (AKA: SelSym Biotechnology Inc)
Profile last edited on: 3/6/2023      CAGE: 8JGX8      UEI: G522J2NEDHD2

Business Identifier: Injectable hemostatic materials
Year Founded
2019
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

101 Linecrest Court
Cary, NC 27518
   (919) 480-8845
   N/A
   www.selsymbio.com
Location: Single
Congr. District: 13
County: Wake

Public Profile

An early stage, preclinical biotech startup spun out of North Carolina State University, the principals of SelSym Biotech are working to transform hemorrhage treatment and wound care through the use of novel synthetic platelet mimetic technologies.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$742,853
Phase II Dollars
$0
Total Awarded
$742,853

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $229,474
Project Title: SymHeal: A novel therapy for treating non-healing diabetic ulcers
2022 1 NIH $258,501
Project Title: Increasing efficiency of sdFv production in a tobacco-based system for synthetic platelet design
2021 1 NIH $254,878
Project Title: Evaluation of stability and safety of platelet-like particles for treating bleeding after trauma

Key People / Management

  Ashley Carson Brown

  Seema Nandi -- Senior Scientist

Company News

Feb 15 2022
New Tech Aims to Tackle 'Disseminated Intravascular Coagulation' Blood Disorder